EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
-11.58%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$406M
AUM Growth
+$406M
(-1.1%)
Cap. Flow
+$52.7M
Cap. Flow
% of AUM
12.98%
Top 10 Holdings %
Top 10 Hldgs %
62.96%
Holding
28
New
–
Increased
11
Reduced
3
Closed
–
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$21.6M |
| 2 |
Natera
NTRA
|
$9.59M |
| 3 |
American Well
AMWL
|
$6.58M |
| 4 |
CANO
Cano Health, Inc.
CANO
|
$6.4M |
| 5 |
DexCom
DXCM
|
$6.24M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$11M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$1.41M |
| 3 |
Humana
HUM
|
$318K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Humana
HUM
$36.5B
| $33.9M | 8.35% |
77,891
-730
| -0.9% | -$318K |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $33.2M | 8.18% |
230,502
+150,002
| +186% | +$21.6M |
|
|
3
AstraZeneca
AZN
$248B
| $29.6M | 7.28% |
445,665
-166,000
| -27% | -$11M |
|
4
United Therapeutics
UTHR
$13.8B
| $28.6M | 7.04% |
159,238
+5,800
| +4% | +$1.04M |
|
5
IQVIA
IQV
$32.4B
| $25.9M | 6.38% |
111,995
+12,418
| +12% | +$2.87M |
|
6
argenx
ARGX
$43.6B
| $22M | 5.43% |
69,900
+7,568
| +12% | +$2.39M |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $21.4M | 5.28% |
82,144
| – | – |
|
8
Alnylam Pharmaceuticals
ALNY
$58.5B
| $21.4M | 5.28% |
131,244
+17,542
| +15% | +$2.86M |
|
|
9
DexCom
DXCM
$29.5B
| $19.9M | 4.9% |
38,900
+12,200
| +46% | +$6.24M |
|
10
Inspire Medical Systems
INSP
$2.77B
| $19.6M | 4.82% |
76,253
| – | – |
|
|
CANO
11
DELISTED
Cano Health, Inc.
CANO
| $18.8M | 4.62% |
2,955,112
+1,007,333
| +52% | +$6.4M |
|
|
12
Natera
NTRA
$23.1B
| $18.2M | 4.49% |
447,494
+235,800
| +111% | +$9.59M |
|
|
AXNX
13
DELISTED
Axonics, Inc. Common Stock
AXNX
| $16.1M | 3.96% |
256,465
| – | – |
|
|
14
American Well
AMWL
$111M
| $16M | 3.95% |
3,811,008
+1,563,100
| +70% | +$6.58M |
|
15
Outset Medical
OM
$247M
| $14.9M | 3.68% |
329,000
| – | – |
|
16
Adaptive Biotechnologies
ADPT
$2.01B
| $14.1M | 3.47% |
1,014,860
+264,100
| +35% | +$3.67M |
|
17
Agios Pharmaceuticals
AGIO
$2.19B
| $12.6M | 3.09% |
431,413
| – | – |
|
|
BPMC
18
DELISTED
Blueprint Medicines
BPMC
| $10.9M | 2.68% |
170,551
-22,088
| -11% | -$1.41M |
|
19
Guardant Health
GH
$8.41B
| $10.1M | 2.48% |
151,960
+32,600
| +27% | +$2.16M |
|
|
CMAX
20
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $5.34M | 1.32% |
714,755
| – | – |
|
|
MRTX
21
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.28M | 1.05% |
52,000
| – | – |
|
22
4D Molecular Therapeutics
FDMT
$288M
| $2M | 0.49% |
132,090
| – | – |
|
23
Beam Therapeutics
BEAM
$1.66B
| $1.66M | 0.41% |
28,900
| – | – |
|
24
Kymera Therapeutics
KYMR
$2.95B
| $1.57M | 0.39% |
37,000
| – | – |
|
25
Arvinas
ARVN
$568M
| $1.55M | 0.38% |
23,000
| – | – |
|